Official Full Name |
Recombinant Rat Macrophage-Derived Chemokine/CCL22 (rRtMDC/CCL22) |
Squence |
 |
Amino Acid Sequence |
GPYGANVEDS ICCQDYIRHP LPPRFVKEFY WTSKSCRKPG VVLITIKNRD ICADPRMLWV KKILHKLA |
Synonyms |
STCP-1, MDC (1-69), Macrophage-derived Chemokine |
Accession Number |
|
GeneID |
|
Summary |
|
Source |
Escherichia coli. |
Molecular Weight |
Approximately 7.9 kDa, a single, non-glycosylated polypeptide chain containing 68 amino acids. |
Biological Activity |
Fully biologically active when compared to standard. The biologically active determined by a chemotaxis bioassay using human T-lymphocytes is in a concentration range of 10-100 ng/ml. |
Appearance |
Sterile Filtered White lyophilized (freeze-dried) powder. |
Formulation |
Lyophilized from a 0.2 um filtered concentrated solution in 2 × PBS, pH7.4. |
Endotoxin |
Less than 1 EU/ug of rRtMDC/CCL22 as determined by LAL method. |
Reconstitution |
We recommend that this vial be briefly centrifuged prior to opening to bring the contents to the bottom. Reconstitute in sterile distilled water or aqueous buffer containing 0.1 % BSA to a concentration of 0.1-1.0 mg/ml. Stock solutions should be apportioned into working aliquots and stored at ≤ -20 °C. Further dilutions should be made in appropriate buffered solutions. |
Stability and Storage |
Use a manual defrost freezer and avoid repeated freeze-thaw cycles.- 12 months from date of receipt, -20 to -70 °C as supplied.- 1 month, 2 to 8 °C under sterile conditions after reconstitution.- 3 months, -20 to -70 °C under sterile conditions after reconstitution. |
References |
1. Nomiyama H, Imai T, Kusuda J, et al. 1998. Cytogenet Cell Genet, 81: 10-1.2. Godiska R, Chantry D, Raport CJ, et al. 1997. J Exp Med, 185: 1595-604.3. Yamashita UandKuroda E. 2002. Crit Rev Immunol, 22: 105-14.4. Katou F, Ohtani H, Nakayama T, et al. 2001. Am J Pathol, 158: 1263-70. |
SDS-PAGE |
 |
Safety Data Sheet (SDS) Download |
Click to download |
Technical Data Sheet (TDS) Download |
Click to download |